ZNF493 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.867200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.329600E-01
Normal-vs-Stage2
2.846800E-01
Normal-vs-Stage3
2.021000E-01
Normal-vs-Stage4
3.050600E-01
Stage1-vs-Stage2
8.063800E-02
Stage1-vs-Stage3
5.611600E-02
Stage1-vs-Stage4
3.801800E-01
Stage2-vs-Stage3
1.084820E-01
Stage2-vs-Stage4
7.745400E-01
Stage3-vs-Stage4
8.560200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.885200E-01
Normal-vs-AfricanAmerican
3.294600E-01
Normal-vs-Asian
2.549000E-01
Caucasian-vs-AfricanAmerican
5.872200E-01
Caucasian-vs-Asian
3.490200E-01
AfricanAmerican-vs-Asian
2.805400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.812800E-01
Normal-vs-Female
2.958600E-01
Male-vs-Female
4.917600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.243000E-01
Normal-vs-Age(41-60Yrs)
2.938800E-01
Normal-vs-Age(61-80Yrs)
2.853000E-01
Normal-vs-Age(81-100Yrs)
2.590400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.659360E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.549840E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.281630E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.167000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.310000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.446000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.886600E-01
Normal-vs-Daily Drinker
2.561200E-01
Normal-vs-Weekly Drinker
2.547600E-01
Normal-vs-Occasional Drinker
3.069200E-01
Normal-vs-Social Drinker
2.979600E-01
Non Drinker-vs-Daily Drinker
3.307800E-01
Non Drinker-vs-Weekly Drinker
3.686800E-01
Non Drinker-vs-Occasional Drinker
7.795000E-01
Non Drinker-vs-Social Drinker
8.582400E-01
Daily Drinker-vs-Weekly Drinker
9.367600E-01
Daily Drinker-vs-Occasional Drinker
3.661800E-01
Daily Drinker-vs-Social Drinker
3.207000E-01
Weekly Drinker-vs-Occasional Drinker
3.993600E-01
Weekly Drinker-vs-Social Drinker
3.567800E-01
Occasional Drinker-vs-Social Drinker
9.217400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.217700E-02
Normal-vs-Grade 2
1.028380E-02
Normal-vs-Grade 3
2.805900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.924000E-01
Grade 1-vs-Grade 3
3.749600E-01
Grade 1-vs-Grade 4
7.217700E-02
Grade 2-vs-Grade 3
4.987200E-01
Grade 2-vs-Grade 4
1.028380E-02
Grade 3-vs-Grade 4
2.805900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.808400E-01
Normal-vs-NonDiabetic
2.779600E-01
Diabetic-vs-NonDiabetic
9.252000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.493600E-01
Normal-vs-NoPancreatitis
2.794600E-01
Pancreatitis-vs-NoPancreatitis
3.602800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.953400E-01
Normal-vs-N1
2.819800E-01
N0-vs-N1
6.407400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.978000E-01
Normal-vs-TP53-NonMutant
3.948000E-01
TP53-Mutant-vs-TP53-NonMutant
5.684100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
